With an aging population in the Western world, a growing proportion of patients treated in praticacardiologica is represented by the elders.
Although about a third of patients admitted with acute coronary syndrome (ACS) is older than 75 years and the mortality rate in this age group has doubled compared to younger patients, this population is underrepresented in randomized controlled trials and, therefore, the guidelines often do not provide clear guidance for the management of elderly patients.
Therefore, there is need for clinical guidance regarding this subpopulation dipazienti with SCA growing rapidly, considering the fact claws decisions on the optimal antithrombotic therapy strategies in the elderly are often difficult and complex, also in relation to the presence of dysfunction d ' age-related organ, frequent comorbidity and multiple concomitant medications, and ultimately increase the risk of both ischemic stroke is hemorrhagic in elderly patients.